475 crore. Exceptional item (net of tax) in FY24 pertains to transaction costs relating to the acquisition of the biologics manufacturing facility from Stelis Biopharma Limited (SBL). Exceptional item ...

The German science & technology company Merck, in association with Stelis Biopharma Pvt Ltd, has launched its first joint bioprocess scale-up lab in Bengaluru to provide end-to-end solutions from ...

The company has reported total income of Rs. 588.23 crores during the period ended March 31, 2025 as compared to Rs. 345.97 crores during the period ended December 31, 2024. The company has posted net ...

The business reported a Net Interest Income (NII) registered a growth of 1.5% to ₹42,774 Crore versus ₹41,655 Crore in Q4FY24.

Support our non-profit newsroom: safeguard HKFP's future and help keep trusted, independent news free-to-access for all. 1. Donate by card or PayPal. Make a one-off or monthly contribution ...

Quant Small Cap Fund - Direct (G) 271.53 16,70,468 1.04 Quant Small Cap Fund - Direct (IDCW) 271.53 16,70,468 1.04 Motilal Oswal Large and Midcap Fund (G) 209.16 12,86,754 2.28 Motilal Oswal Large and ...